THE STEM CELL MARKER SALL4 AND CIRCULATING TUMOR CELLS AS BIOMARKERS FOR PROSTATE CANCER PROGNOSES AND THERAPEUTICS

Nevada Cancer Institute, Las Vegas NV

Investigators